Phathom Pharmaceuticals Announces Regulatory Update and Plans for 2023 Erosive Esophagitis and H. pylori Commercial Launch
Favorable feedback following meeting with the U.S. Food and Drug Administration (FDA) allows for planned…
Month: April 2023
Phathom Pharmaceuticals Announces Regulatory Update and Plans for 2023 Erosive Esophagitis and H. pylori Commercial Launch
Favorable feedback following meeting with the U.S. Food and Drug Administration (FDA) allows for planned…
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel’s Ministry of Health
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel’s Ministry of Health
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
BERLIN and INDIANAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) — Eckert & Ziegler (ISIN DE0005659700, TecDAX)…
Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
BERLIN and INDIANAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) — Eckert & Ziegler (ISIN DE0005659700, TecDAX)…
Repairon Announces Completion of Dose-Finding Part of BioVAT-HF Phase 1/2 Trial in Advanced Heart Failure
Feasibility and safety demonstrated in patients with advanced heart failure Safe maximal dose for continuation…
Repairon Announces Completion of Dose-Finding Part of BioVAT-HF Phase 1/2 Trial in Advanced Heart Failure
Feasibility and safety demonstrated in patients with advanced heart failure Safe maximal dose for continuation…
Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech
Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP…
Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech
Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP…
Nephros Announces Preliminary Results for First Quarter 2023
SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq:…
Nephros Announces Preliminary Results for First Quarter 2023
SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq:…
Biogen Appoints Adam Keeney as Head of Corporate Development
CAMBRIDGE, Mass., April 04, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the…
Alterity Therapeutics Enrolls First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
MELBOURNE, Australia and SAN FRANCISCO, April 04, 2023 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH,…
Verizon continues to upgrade Jacksonville’s best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
Verizon continues to upgrade Jacksonville’s best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
Verizon continues to upgrade Portland’s best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
Verizon continues to upgrade Portland’s best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
Verizon Business to showcase its connected healthcare solutions at HIMSS 2023
Verizon, the network America relies on, will demonstrate the latest 5G innovations to drive Enterprise…
Verizon Business to showcase its connected healthcare solutions at HIMSS 2023
Verizon, the network America relies on, will demonstrate the latest 5G innovations to drive Enterprise…